de Mazancourt P, Giot J, Giudicelli Y
Department of Biochemistry, Faculty of Medicine Paris-Ouest, Centre Hospitalier de Poissy, Poissy, France.
Horm Metab Res. 1990 Jan;22(1):22-4. doi: 10.1055/s-2007-1004840.
The ability of glucocorticoid-treatment to reverse the metabolic alterations caused by adrenalectomy in rat adipocytes was studied. Correction of the enhanced adenosine antilipolytic effect and of the defect in lipolysis, cyclic AMP and adenylate cyclase responsiveness to guanine nucleotides were all achieved after a 24 h dexamethasone treatment, whereas correction of the defect in beta-adrenoceptor-density required a 48 h treatment. The latter treatment, however, failed to reverse the defect in both the adenylate cyclase catalytic activity and protein content per fat cell. These different kinetics of restoration indicate that correction by dexamethasone of the defective cyclic AMP and lipolytic responses on one hand and of the guanine nucleotide control of adenylate cyclase on the other one are two related phenomenoms.
研究了糖皮质激素治疗逆转大鼠脂肪细胞肾上腺切除引起的代谢改变的能力。地塞米松治疗24小时后,增强的腺苷抗脂解作用以及脂解、环磷酸腺苷(cAMP)和腺苷酸环化酶对鸟嘌呤核苷酸反应性的缺陷均得到纠正,而β-肾上腺素能受体密度的缺陷纠正需要48小时治疗。然而,后一种治疗未能逆转每个脂肪细胞的腺苷酸环化酶催化活性和蛋白质含量的缺陷。这些不同的恢复动力学表明,地塞米松一方面纠正有缺陷的cAMP和脂解反应,另一方面纠正腺苷酸环化酶的鸟嘌呤核苷酸控制,是两个相关的现象。